Your browser doesn't support javascript.
loading
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Chee, Cheng E; Ooi, Melissa; Lee, Soo-Chin; Sundar, Raghav; Heong, Valerie; Yong, Wei-Peng; Ng, Chin Hin; Wong, Andrea; Lim, Joline S J; Tan, David S P; Soo, Ross; Tan, Joshua T C; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo; Zeng, Qi; Goh, Boon-Cher.
Afiliação
  • Chee CE; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore. mdccce@nus.edu.sg.
  • Ooi M; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. mdccce@nus.edu.sg.
  • Lee SC; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Sundar R; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Heong V; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Yong WP; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Ng CH; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Wong A; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Lim JSJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Tan DSP; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Soo R; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Tan JTC; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Yang S; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Thura M; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Al-Aidaroos AQ; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Chng WJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Zeng Q; Department of Hematology-Oncology, National University Cancer Institute, Singapore (NCIS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore.
  • Goh BC; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Target Oncol ; 18(3): 391-402, 2023 05.
Article em En | MEDLINE | ID: mdl-37060431
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias Hematológicas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias Hematológicas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article